Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Dermapharm is a leading German pharmaceutical company dedicated to the development, production, and distribution of high-quality medicinal products. Its comprehensive portfolio includes generics, innovative branded products, and natural remedies across various therapeutic areas. Dermapharm plays a significant role in advancing public health.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Dermapharm is scheduled to report its next quarterly earnings on 11/12/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Dermapharm last reported quarterly earnings on 8/25/2026 (Q2 2026). Earnings per share (EPS) came in at 0.47 EUR.
Across its last 3 earnings reports, Dermapharm stock moved by ±3.4% on average the following day. The largest reaction was +8.5% on 03/10/2026; 3 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.